Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Caregiver Treatment Preferences for Children with a New Versus Existing Attention-Deficit/Hyperactivity Disorder Diagnosis.

dosReis S, Park A, Ng X, Frosch E, Reeves G, Cunningham C, Janssen EM, Bridges JFP.

J Child Adolesc Psychopharmacol. 2017 Apr;27(3):234-242. doi: 10.1089/cap.2016.0157. Epub 2016 Dec 19.

2.

A Latent Class Analysis to Identify Variation in Caregivers' Preferences for their Child's Attention-Deficit/Hyperactivity Disorder Treatment: Do Stated Preferences Match Current Treatment?

Ng X, Bridges JF, Ross MM, Frosch E, Reeves G, Cunningham CE, dosReis S.

Patient. 2017 Apr;10(2):251-262. doi: 10.1007/s40271-016-0202-z.

3.

Using Best-Worst Scaling to Measure Caregiver Preferences for Managing their Child's ADHD: A Pilot Study.

dosReis S, Ng X, Frosch E, Reeves G, Cunningham C, Bridges JF.

Patient. 2015 Oct;8(5):423-31. doi: 10.1007/s40271-014-0098-4.

5.

Systematic Review of Patients' and Parents' Preferences for ADHD Treatment Options and Processes of Care.

Schatz NK, Fabiano GA, Cunningham CE, dosReis S, Waschbusch DA, Jerome S, Lupas K, Morris KL.

Patient. 2015 Dec;8(6):483-97. doi: 10.1007/s40271-015-0112-5. Review.

PMID:
25644223
6.

A best-worst scaling experiment to prioritize caregiver concerns about ADHD medication for children.

Ross M, Bridges JF, Ng X, Wagner LD, Frosch E, Reeves G, dosReis S.

Psychiatr Serv. 2015 Feb 1;66(2):208-11. doi: 10.1176/appi.ps.201300525. Epub 2014 Nov 17.

7.

Early Morning Functional Impairments in Stimulant-Treated Children with Attention-Deficit/Hyperactivity Disorder Versus Controls: Impact on the Family.

Faraone SV, Schachar RJ, Barkley RA, Nullmeier R, Sallee FR.

J Child Adolesc Psychopharmacol. 2017 Oct;27(8):715-722. doi: 10.1089/cap.2016.0164. Epub 2017 Apr 10.

8.

Early Morning Functioning in Stimulant-Treated Children and Adolescents with Attention-Deficit/Hyperactivity Disorder, and its Impact on Caregivers.

Sallee FR.

J Child Adolesc Psychopharmacol. 2015 Sep;25(7):558-65. doi: 10.1089/cap.2014.0160. Epub 2015 Jul 7.

9.
10.

Assessment of parents' preferences for the treatment of school-age children with ADHD: a discrete choice experiment.

Fegert JM, Slawik L, Wermelskirchen D, Nübling M, Mühlbacher A.

Expert Rev Pharmacoecon Outcomes Res. 2011 Jun;11(3):245-52. doi: 10.1586/erp.11.22. Review.

PMID:
21671692
11.

Physician perceptions of the use of medications for attention deficit hyperactivity disorder.

Stockl KM, Hughes TE, Jarrar MA, Secnik K, Perwien AR.

J Manag Care Pharm. 2003 Sep-Oct;9(5):416-23.

12.

Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.

Zwi M, Jones H, Thorgaard C, York A, Dennis JA.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD003018. doi: 10.1002/14651858.CD003018.pub3. Review.

PMID:
22161373
13.

Parent-Reported Improvements in Family Functioning in a Randomized Controlled Trial of Lisdexamfetamine for Treatment of Parental Attention-Deficit/Hyperactivity Disorder.

Babinski DE, Waxmonsky JG, Waschbusch DA, Humphery H, Pelham WE Jr.

J Child Adolesc Psychopharmacol. 2017 Apr;27(3):250-257. doi: 10.1089/cap.2016.0129. Epub 2016 Dec 19.

PMID:
27991835
14.

Parent preferences regarding stimulant therapies for ADHD: a comparison across six European countries.

Nafees B, Setyawan J, Lloyd A, Ali S, Hearn S, Sasane R, Sonuga-Barke E, Hodgkins P.

Eur Child Adolesc Psychiatry. 2014 Dec;23(12):1189-200. doi: 10.1007/s00787-013-0515-6. Epub 2014 Jan 18.

15.

Health state utilities for childhood attention-deficit/hyperactivity disorder based on parent preferences in the United kingdom.

Secnik K, Matza LS, Cottrell S, Edgell E, Tilden D, Mannix S.

Med Decis Making. 2005 Jan-Feb;25(1):56-70.

PMID:
15673582
16.

Parental perceptions and satisfaction with stimulant medication for attention-deficit hyperactivity disorder.

Dosreis S, Zito JM, Safer DJ, Soeken KL, Mitchell JW Jr, Ellwood LC.

J Dev Behav Pediatr. 2003 Jun;24(3):155-62.

PMID:
12806227
17.

Association between quality of life and treatment response in children with attention Deficit Hyperactivity Disorder and their parents.

van der Kolk A, Bouwmans CA, Schawo SJ, Buitelaar JK, van Agthoven M, Hakkaart-van Roijen L.

J Ment Health Policy Econ. 2014 Sep;17(3):119-29.

PMID:
25543115
18.

A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.

Pelham WE, Aronoff HR, Midlam JK, Shapiro CJ, Gnagy EM, Chronis AM, Onyango AN, Forehand G, Nguyen A, Waxmonsky J.

Pediatrics. 1999 Apr;103(4):e43.

PMID:
10103335
19.

The Caregiver Perspective on Paediatric ADHD (CAPPA) survey: Understanding sociodemographic and clinical characteristics, treatment use and impact of ADHD in Europe.

Flood E, Gajria K, Sikirica V, Dietrich CN, Romero B, Harpin V, Banaschewski T, Quintero J, Erder MH, Fridman M, Chen K.

J Affect Disord. 2016 Aug;200:222-34. doi: 10.1016/j.jad.2016.04.011. Epub 2016 Apr 12.

20.

A discrete choice conjoint experiment to evaluate parent preferences for treatment of young, medication naive children with ADHD.

Waschbusch DA, Cunningham CE, Pelham WE, Rimas HL, Greiner AR, Gnagy EM, Waxmonsky J, Fabiano GA, Robb JA, Burrows-Maclean L, Scime M, Hoffman MT.

J Clin Child Adolesc Psychol. 2011;40(4):546-61. doi: 10.1080/15374416.2011.581617.

Supplemental Content

Support Center